Avantor, Inc.
Key Metrics
- Previous Close
- $13.96
- 52-Week Range
- $7.27 – $15.93
- Market Cap
- $9.64B
- P/E (TTM)
- —
- EPS (TTM)
- -0.87
- Dividend Yield
- —
Advanced Metrics
- Price/Book
- 1.71
- PEG Ratio
- —
- Return on Equity
- -9.70%
- Return on Assets
- 2.69%
- Gross Margin
- 31.82%
- Operating Margin
- 7.16%
- Profit Margin
- -8.81%
- Current Ratio
- 1.78
- Debt/Equity
- 0.66
- Total Debt
- $3.70B
- Free Cash Flow
- $450.34M
- Revenue Growth
- 0.50%
- Earnings Growth
- -37.40%
- Enterprise Value
- $13.03B
Market Snapshot
About
Avantor, Inc. is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education, government, and advanced technologies industries. The company produces and distributes high-purity materials, chemicals, reagents, laboratory equipment, instruments, and consumables used in scientific research, pharmaceutical manufacturing, and diagnostics. Avantor operates through Laboratory Solutions (chemicals, reagents, kits, instruments, consumables for research and quality control) and Bioscience Production (single-use technologies, bioprocess chemicals, and equipment for biopharmaceutical manufacturing). The company serves customers through its VWR distribution platform, one of the largest global scientific supply chains. Avantor also provides proprietary products including J.T. Baker chemicals and NuSil silicones. Founded in 1904 and headquartered in Radnor, Pennsylvania, Avantor benefits from growth in biopharmaceutical production, personalized medicine, gene and cell therapy, and scientific research funding while leveraging its integrated manufacturing and distribution capabilities.